XML 20 R5.htm IDEA: XBRL DOCUMENT v3.24.2
EPT - Condensed Consolidated Statements of Equity for the three and six months ended June 30, 2024 and 2023 (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Distributions in excess of accumulated earnings
Accumulated other comprehensive income, net
Noncontrolling interest
Balance at period beginning (in shares) at Dec. 31, 2022   64,605        
Balance at period beginning at Dec. 31, 2022 $ 5,895,116 $ 6 $ 6,750,076 $ (1,080,176) $ 46,466 $ 178,744
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 267,350     253,152   14,198
Change in fair value of derivatives and amortization of swap settlements 5,092       4,919 173
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   3        
Sale of common stock, net (125)   (125)      
Equity based compensation costs 7,646   7,387     259
Retirement of common stock, net (in shares)   (437)        
Retirement of common stock, net (95,657)   (95,657)      
Changes in the redemption value of redeemable noncontrolling interest (4,205)   (4,087)     (118)
Distributions to noncontrolling interest (16,033)         (16,033)
Redemptions of noncontrolling interest (in shares)   12        
Redemptions of noncontrolling interest (609)   (113)     (496)
Common stock dividends (296,570)     (296,570)    
Balance at period end (in shares) at Jun. 30, 2023   64,183        
Balance at period end at Jun. 30, 2023 5,762,005 $ 6 6,657,481 (1,123,594) 51,385 176,727
Balance at period beginning (in shares) at Mar. 31, 2023   64,182        
Balance at period beginning at Mar. 31, 2023 5,796,857 $ 6 6,657,183 (1,074,930) 36,522 178,076
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 105,756     99,620   6,136
Change in fair value of derivatives and amortization of swap settlements 15,386       14,863 523
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   1        
Sale of common stock, net (53)   (53)      
Equity based compensation costs 1,982   1,915     67
Changes in the redemption value of redeemable noncontrolling interest (1,147)   (1,160)     13
Distributions to noncontrolling interest (8,056)         (8,056)
Redemptions of noncontrolling interest (436)   (404)     (32)
Common stock dividends (148,284)     (148,284)    
Balance at period end (in shares) at Jun. 30, 2023   64,183        
Balance at period end at Jun. 30, 2023 5,762,005 $ 6 6,657,481 (1,123,594) 51,385 176,727
Balance at period beginning (in shares) at Dec. 31, 2023   64,203        
Balance at period beginning at Dec. 31, 2023 5,593,978 $ 6 6,656,720 (1,267,536) 33,556 171,232
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 384,126     365,645   18,481
Change in fair value of derivatives and amortization of swap settlements 5,508       5,321 187
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   7        
Stock option and restricted stock plans, net 962   962      
Sale of common stock, net (113)   (113)      
Equity based compensation costs 3,743   3,616     127
Changes in the redemption value of redeemable noncontrolling interest (1,684)   (1,623)     (61)
Distributions to noncontrolling interest (17,075)         (17,075)
Redemptions of noncontrolling interest (279)   (249)     (30)
Common stock dividends (314,666)     (314,666)    
Balance at period end (in shares) at Jun. 30, 2024   64,210        
Balance at period end at Jun. 30, 2024 5,654,500 $ 6 6,659,313 (1,216,557) 38,877 172,861
Balance at period beginning (in shares) at Mar. 31, 2024   64,209        
Balance at period beginning at Mar. 31, 2024 5,723,753 $ 6 6,658,882 (1,152,136) 41,279 175,722
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 98,986     92,914   6,072
Change in fair value of derivatives and amortization of swap settlements (2,487)       (2,402) (85)
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   1        
Sale of common stock, net (105)   (105)      
Equity based compensation costs 2,048   1,979     69
Changes in the redemption value of redeemable noncontrolling interest (1,697)   (1,443)     (254)
Distributions to noncontrolling interest (8,663)         (8,663)
Common stock dividends (157,335)     (157,335)    
Balance at period end (in shares) at Jun. 30, 2024   64,210        
Balance at period end at Jun. 30, 2024 $ 5,654,500 $ 6 $ 6,659,313 $ (1,216,557) $ 38,877 $ 172,861